The effects of benzyltrimethylammonium bromide (BTM) on the guinea-pig vas deferens.
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D004357:Drug Synergism; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010477:Perfusion; D011189:Potassium Chloride / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013268:Stimulation, Chemical; D014649:Vas Deferens / Q000187:drug effects*
D001593:Benzyl Compounds; D001949:Bretylium Compounds; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; C000168:benzyltrimethylammonium; D011189:Potassium Chloride; D003042:Cocaine; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine